baber/WOPTO huggingface dataset:
Patent NZ-332982-A (NZ)
Title: a biomedical moulding comprising an amphiphilic segmented copolymer of controlled morphology having at least one oxygen permeable polymer and at least one ion and water permeable polymer
Inventor: HIRT THOMAS
IPC: G02B1/04
Filed: 1997-06-19
Abstract: A biomedical moulding such as a contact lens is claimed which is obtained by polymerizing in a biomedical mould an amphiphilic segmented copolymer consisting essentially of: a) at least one oxyperm polymer segment (A) comprising a polysiloxane, a perfluoroalkyl polyether or a polymer of a conjugated aliphatic or alicyclic diene and b) at least one ionoperm polymer segment (B) which is obtained by polymerizing a cyclic imino ether of the formula above wherein R9 is alkenyl or hydroxyalkyl or the 2-isocyanatoethyl methacrylate adduct of the hydroxyalkyl and t is 2 or 3; Wherein segment A and segment B are linked together through a covalent bond which is not cleaved by an ordinary aqueous or solvent hydrolysis reaction under acidic or basic conditions and wherein the copolymer contains at least one polymerizable unsaturated group.
Patent NZ-334299-A (NZ)
Title: Fat emulsion containing xanthine derivative
Inventor: HOSOKAWA TOSHIHITO
IPC: C07D473/08
Filed: 1997-08-07
Abstract: <CHEM> A fat emulsion comprising a xanthine derivative represented by general formula (I) or a pharmacologically acceptable salt thereof, wherein R<1> and R<2> represent each independently substituted or unsubstituted lower alkyl, and Q represents hydrogen, hydroxyl or substituted hydroxyl.
Patent NZ-334479-A (NZ)
Title: Method for introducing genes into fetal cells using a gene transporter
Inventor: TSUKAMOTO MAKOTO
IPC: A01K67/027
Filed: 1995-08-31
Abstract: The method involves a gene-containing composition including a gene and a transporter that is capable of transferring the gene from the maternal body to foetal cells.   An example of such a transporter is dioctadecylamide glycylspermine (DOGS).  The composition, when administered to the maternal body, serves to prevent the birth of children suffering from gene deletion and to cure gene deletion during gestation.  It is also possible, by conducting an animal experiment for introducing unknown genes in an embryonic stage, to clarify the function to be performed by the same in development.  The composition may be used for breeding animals such as pets, industrial animals and cattle.
Patent NZ-335766-A (NZ)
Title: Naphthyridine derivatives and use as acyl-CoA cholesterol acyl transferase(ACAT) inhibitor as treatment of hyperlipidemia
Inventor: MURAOKA MASAMI
IPC: C07D471/04
Filed: 1997-11-25
Abstract: The specification describes a naphthyridine derivative or an acid addition salt thereof, which shows acyl-CoA: cholesterol acyl transferase (ACAT) inhibitory activity, and is useful as an agent for treatment of hyperlipidemia and atherosclerosis, and a use thereof.  The  naphthyridine derivative is of the formula:  wherein Ring A is a substituted or unsubstituted pyridine ring,  X is a group of the formula:  wherein R2 is a hydrogen atom, an alkyl group, a substituted alkyl group, an alkenyl group, a substituted alkenyl group, an alkynyl group, a substituted alkynyl group, a cycloalkyl group, or a substituted cycloalkyl group, or a group of the formula:  wherein R is a hydrogen atom or a group: -OR1 wherein (R1 is an alkyl group, a substituted alkyl group, an alkenyl group, a substituted alkenyl group, an alkynyl group, or a substituted alkynyl group), Z is a direct bond, -NH-, an alkylene group having 1 to 2 carbon atoms, or -CH=CH-, Y is an aromatic group or a substituted aromatic group, L is an alkyl group, a substituted alkyl group, an alkenyl group, a substituted alkenyl group, a cycloalkyl group, a substituted cycloalkyl group, an aromatic group, or a substituted aromatic group, or an acid addition salt thereof.
Patent NZ-336092-A (NZ)
Title: Expression of vectors containing portions of murine CD40 or FAS ligand gene for gene therapy treatment of autoimmune and malignancy diseases
Inventor: KIPPS THOMAS J
IPC: A61K39/00
Filed: 1997-12-08
Abstract: A gene that encodes for an accessory molecule ligand and the use for immunomodulation, vaccination and treatments of various human diseases, including malignancies and autoimmune diseases. The accessory molecule ligand is expressed on the surface of the cells, wherein the accessory molecule ligand has a greater stabilized activity relative to a corresponding native accessory molecule ligand. The accessory molecule ligand which is made up of various domains and subdomain portions of molecules derived from the tumour necrosis factor family. The chimeric molecule contains unique properties, which leads to the stabilisation of the activities and thus greater usefulness in the treatment of diseases.
Patent NZ-336111-A (NZ)
Title: Substituted tetrahydropyridine derivatives, method of preparation and pharmaceutical compositions for treating memory disorders
Inventor: MARAZANO CHRISTIAN
IPC: A61P25/16
Filed: 1997-12-02
Abstract: Described are tetrahydropyridine derivatives synthesized as nicotinic ligands possessing promnestic properties for the treatment of memory defects associated with cerebral ageing like Alzheimer's disease. The compounds are of the formula 1 where X is H Y is OH or X and Y form an oxo group, R is linear or branched C1-6 alkyl group, or phenyl optionally substituted with one or more halogen atoms or one or more linear or branched C1-6 alkyl, C1-6 alkoxy, linear or branched C1-6 polyhaloalkyl or hydroxyl groups, R1 is H or a group of the formula 2 where X' is H Y' is hydroxyl or X' and Y' simultaneously represent a linear or branched C1-6 alkoxy group or X' and Y' form an oxo group or a linear or branched C1-4 alkylenedioxy group, R3 is linear or branched C1-6 alkoxy group or a phenyl group substituted with halogen atoms R2 is H or linear or branched C1-6 alkyl group optionally substituted Where R and R2 both represent a CH3, X is H, Y is OH and R1 is formula 2 where X' is H, Y'is OH, then R3 cannot be phenyl.
Patent NZ-337399-A (NZ)
Title: O-sulfated K4, K5 and K40 bacterial polysaccharides
Inventor: ZOPPETTI GIORGIO
IPC: C08B37/10
Filed: 1998-02-04
Abstract: rocess for the preparation of O-sulfated K4, K5 and K40 polysaccharides useful for the treatment of tumoral, HIV-1 and coagulation pathologies and in cosmetic preparations, wherein the K4, K5 or K40 polysaccharide in the form of sodium salt is suspended in an aprotic solvent and directly submitted to the reaction of O-sulfation with a pyridine-sulphur trioxide or trimethylamine-sulphur trioxide adduct or with chlorosulfonic acid.  Also included is the use of said O-sulfated polysaccharides in the treatment of tumoral, HIV-1 and coagulation pathologies, cosmetic compositions and in the prevention of hair loss.
Patent NZ-501428-A (NZ)
Title: Thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives useful for conditions such as insulin resistance
Inventor: NORDEN BO
IPC: A61P3/10
Filed: 1998-06-04
Abstract: Thialzolidinedione, oxazolidinedione and oxadiazolidinedione derivatives of the Formula (I) for treating clinical conditions associated with insulin resistance and processes for preparing such derivatives and compositions are described. Wherein; R is H or alkyl, A is S, O or NH, B is C, CH or N, D is situated in the orto, meta or para position and is representing CN or -X-Y-Z, D' is situated in the orto, meta or para position and is representing H, -O-alkyl, alkyl, halogen or -X-Y-Z, wherein X is O, NR1, SO2 or S and R1 is H or alkyl, Y is SO2, CO or a chemical bond, Z is alkyl, alkyl substituted by one or more fluoro or chloro atoms, aryl, substituted aryl, alkyl aryl, OR2 orNHR3, wherein R2 is alkyl, aryl, alkylaryl, substituted aryl or substituted alkyl and R3 is H, alkyl, aryl, alkylaryl, substituted aryl or substituted alkyl provided that; When X is O or NR1, then Y is either SO2 or CO and Z is, when Y is a) SO2, selected from the group consisting of alkyl, alkyl substituted by one or more fluoro or chloro atoms, aryl, substituted aryl and alkylaryl, when Y is b) CO, selected from the group consisting of OR2, wherein R2 is as defined, When X is SO2, then Y is a chemical bond and Z is selected from the group consisting of alkyl, alkyl substituted by one or more fluoro or chloro atoms, aryl, substituted aryl, alkylaryl and OR2, wherein R2 is as defined above, When X is S, then Y is a chemical bond and Z is selected from the group consisting of alkyl, alkyl substituted by one or more fluoro or chloro atoms, aryl, substituted aryl alkylaryl, and further provided that when B is N, A is O.
Patent NZ-503288-A (NZ)
Title: New and useful improvements in fiber-reinforced composite materials structures and methods of making same
Inventor: BURGESS KEITH E
IPC: B32B5/00
Filed: 1999-06-28
Abstract: Reinforcement preforms (10) are provided for use in fiber-reinforced composite materials structures.   The reinforcement preforms comprise first and second reinforcement preform elements (12, 14) that include strength reinforcement fibers that are in desired directional orientation. The first element (14) has a cross-fiber surface (18) that extends transverse of its constituent strength reinforcement fibers and is in contacting juxtaposition to a selected surface region (20) of the second element (12), forming an abutment therebetween. Abutment strength reinforcing fibers (16), which may optionally be introduced in situ by a continuum of fibers, such as a yarn or thread, extend through at least a portion of the second element (12) and its selected surface region, the abutment, the cross-fiber edge surface (18), and into the first element (14) substantially in the direction of orientation (Y) of its constituent strength fibers to which its cross-fiber surface is transverse.
Patent NZ-511411-A (NZ)
Title: Benzisoxazoles and phenones as alpha2-antagonists
Inventor: MERTENS JOSEPHUS CAROLUS
IPC: A61P15/10
Filed: 1999-12-14
Abstract: A compound of formula (I), a N-Oxide form, pharmaceutically acceptable salt or stereochemically isomeric form thereof, wherein: Alk is 1,5-pentanediyl, n is 1 or 2, p is 1 and q is 2, or p is 2 and q is 1, X is -O-, -S- or NH, R1 is independently hydrogen, halogen, C1-6alkyl, nitro, hydroxy or C1-4alkyloxy, D is a radical of formula (a) or formula (b), wherein: m is 1 or 2, R3 is independently is hydrogen, C1-4alkyl, C1-4alkyloxy or halogen. Also described is the use of a compound of formula (I) in the manufacture of a medicament for treating depression or Parkinson's disease.
Patent NZ-512747-A (NZ)
Title: Ionomeric, puncture resistant, thermoplastic patch bag, film, blend and process
Inventor: GEORGELOS PAUL NICK
IPC: B32B27/08
Filed: 2001-07-03
Abstract: Described is a blend, film (112), and patch bag (110) combination of: (a) a bag having inside and outside surfaces (128) comprising a flexible, thermoplastic, biaxially stretched, heat shrinkable film having at least one blend layer having at least three copolymers comprising: 45 to 85 weight percent of a polymer (having a melting point of 55 to 98oC) comprising a copolymer of ethylene and hexane-1 or octane-1; 5 to 35 weight % of a second polymer (having a melting point of from 115 to 128oC) comprising a copolymer of ethylene and at least one á-olefin; and 10 to 50 weight percent of a third polymer (having a melting point of from 60 to 110oC) comprising an unmodified or anhydride-modified copolymer of ethylene and a vinyl ester, acrylic acid, methacrylic acid, or an alkyl acrylate; where the first and second polymers above have a combined weight percentage > 50 weight % based upon their total weight; and the bag film has a total energy absorption > 0.07 Joule and a shrinkage value of 90oC > 50% in at least one of the machine and transverse directions; and (b) a patch (114) film attached to at least one surface of the bag and covering at least 25% of the bag's surface where this patch file comprises a flexible, thermoplastic file comprising a blend of > 2 polymer comprising: 5 to 20 weight % of (i) an ionomer polymer e.g. an ethylene-methacrylate acid copolymer whose acid groups have been neutralised partly or completely to form a salt, preferably a zinc or sodium salt; 5 to 95 weight % of (ii) a copolymer of ethylene and at least one C6-C8 á-olefin, (melting point of from 55 to 95oC and an average of Mw/Mn of 1.5 to 3.5); 0 to 90 weight % of (iii) a copolymer of ethylene and at least one C4 and C8 á-olefin, (melting point of 100 to 125oC); and 0 to 90 weight percent of (iv) a copolymer of propylene and ethylene or butene-1 (melting point of 105 to 145oC); and 0 to 90 weight % of (v) a copolymer of ethylene and hexane-1, octane-1 and/or decene-1, (melting point of 125 to 135oC); and polymers (ii) (iii) (iv) and (v) have a combined weight % of > 80 weight % based upon the total weight of polymers (i), (ii), (iii), (iv), and (v); and the patch film has a total energy absorption of > 1.2 Joule, and process for making same.
Patent NZ-513228-A (NZ)
Title: Pallet made from cardboard with beams made from cardboard tubes
Inventor: RANTANEN KARI
IPC: B65D19/00
Filed: 2001-07-31
Abstract: A pallet, including beams in a parallel arrangement, composed of tubular core members of cardboard substantially perpendicular to the plane of the pallet as well as a sheet of board surrounding the tubular cores, as well as at least one element set against the beans for bracing the beams, characterized in that the beams are encapsulated by folding the sheet of board around the respective cardboard core members such that the sheet constitutes a bottom and sides for the beam and closes the beam at each end thereof.
Patent NZ-513978-A (NZ)
Title: Method for evaluating routes in a communications network
Inventor: RAMMER JOSEF
IPC: H04L45/02
Filed: 2000-04-20
Abstract: The aim is to evaluate routes R in a communications network (KN) consisting of switching nodes (K) and of transmission paths (U). To this end, modified link costs (L) are established from link costs (LK) assigned to the transmission paths (U), preferably using random numbers, and the routes (R) are evaluated according to the modified link costs (L). If the modified link costs (L) are established with each call request, connections (V), which can be set-up along a number of routes (R) with identical minimal route costs (RK), are evenly distributed on these routes (R) while retaining existing routing algorithms.
Patent NZ-516197-A (NZ)
Title: Amine oxide/iodine containing blends for wood preservation
Inventor: WALKER LEIGH E
IPC: A01N37/06
Filed: 2000-05-24
Abstract: A single phase aqueous wood preserving composition comprising: - an amine oxide, being trialkylamine oxide, in a preservative enhancing and or waterproofing amount, and - an iodine containing biocide
Patent NZ-519626-A (NZ)
Title: Methods and apparatus for covering a stent
Inventor: RICHTER JACOB
IPC: A61B19/00
Filed: 2002-06-17
Abstract: An intraluminal stent comprising an expandable, tubular support member with a longitudinal axis. A method of making such a intraluminal stent, whereby a stent being expandable from a first diameter to a second diameter is bound by helically winding a strip of expandable covering (e.g. pericardium or collagen threads) around the stent while in its first diameter so that the lateral edges of adjacent windings overlap.
Patent NZ-521736-A (NZ)
Title: Improvements to the bittering of beer
Inventor: WILSON RICHARD J H
IPC: C12C3/12
Filed: 2001-06-26
Abstract: An apparatus for the direct injection of one or more concentrated preparations of isomerised a-acids into wort or beer. Such apparatus containing the following elements: a) a first vessel containing a supply of concentrated isomerised a-acids in the form of their metal salts; b) a heat source for heating the co0nents of said first vessel; c) a second vessel containing heated water; d) a dispensing device for metering the flow of the contents of said first vessel and heated water from said second vessel into a pipeline; and e) an injector fed by said pipeline for injecting diluted, heated, isomerised a-acid into wort or beer.
Patent NZ-524335-A (NZ)
Title: A method of producing a composite body by coalescence and the composite body produced
Inventor: JIANGUO LI
IPC: B29C43/32
Filed: 2001-07-25
Abstract: A method of producing a metallic, ceramic or polymeric body by coalescence has the steps of filling a pre-compacting mould with granular, pelleted or powdered material, pre-compacting the material at least once to remove air and orient the particles, compressing the material in a compression mould by at least one stroke, where a striking unit emits enough kinetic energy to cause coalescence of the material. This process can produce dense bodies with smooth surfaces and small pore volume, and is especially useful for producing orthopaedic implants.
Patent NZ-527305-A (NZ)
Title: Thermally insulating structural components resistant to high temperature corrosive media
Inventor: DE NORA VITTORIO
IPC: C25C/
Filed: 2002-03-04
Abstract: A thermally insulating cover of a cell for the electrowinning of aluminium from alumina dissolved in a fluoride-based molten electrolyte, which cover is inert and resistant to high temperature corrosive media in the form of liquids, vapours and/or gases that are contained in the cell and that comprise vapours from the electrolyte, and which cover during use is exposed to such corrosive media, the cover comprising thermal insulating material shielded from the corrosive media by an openly porous or reticulated alumina structure which is made impermeable by a compact filler made of material resistant and inert to the corrosive media, the filler material comprising compacted particles of refractory material.
Patent NZ-528744-A (NZ)
Title: Catalyst activation process
Inventor: CLARKSON SIMON JAY
IPC: B01J23/75
Filed: 2002-04-05
Abstract: A process for activating a cobalt-containing catalyst by contacting the catalyst with hydrogen in a reaction system suitable for use in a Fischer-Tropsch synthesis wherein a first gaseous stream comprising 0.25 to 5% by volume of hydrogen and 95 to 99.75% by volume of inert gas is continuously introduced into the reaction system and a second gaseous stream is continuously withdrawn from the reactor system wherein the activation procedure comprises the steps of: (A) heating the contents of the reactor system to a temperature which is in a range of 25 to 5 DEG C below a critical activation temperature; (B) thereafter increasing the temperature at a rate of up to 20 DEG C per hour to a first hold temperature which is in a range of from the critical activation temperature to a temperature which is at most 20 DEG C above the critical activation temperature; and (C) maintaining the contents of the reactor system approaches the hydrogen content of the first gaseous stream.
Patent NZ-529178-A (NZ)
Title: Concealed pocket
Inventor: FERMANIS SIMON
IPC: A41D27/20
Filed: 2003-10-24
Abstract: A pocket assembly comprises a first pocket and a second pocket supported by sheet material having a slit therein to provide access to the pocket, each pocket having a mouth having a first edge adjacent to the other pocket and a second edge opposed to the other pocket, each edge being substantially aligned with the slit, wherein the second edges of both pockets are fixed to the sheet material to opposed sides of the slit, the first edges being fixed to each other, a releasable engagement means adapted to releasably engage the first edges and the sheet material in the vicinity of one side of the slit to provide a closure for the second pocket and to thereby conceal the existence of the second pocket when closed.
Patent NZ-533224-A (NZ)
Title: 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof
Inventor: MAILLIET PATRICK
IPC: A61P43/00
Filed: 2002-12-03
Abstract: Disclosed is a compound according to formula (I) wherein: Y is a halogen, linear or branched C1-C7 Alkyl (substituted or unsubstituted), a substituted or unsubstituted cycloalkyl, NH2, NH(R4), N(R4)2, aralkyl, substituted aralkyl, COOH, COO(R4), CONH2, CONH(R4), CON(R4)2, CN in which R4 is an optionally substituted alkyl or cycloalkyl group; Ar2 is a phenyl substituted by R1 and R2 where: one of R1 and R2 is selected from NH2, NH2HZ, NHC(O)-amino acid, N(R5)2 in which R5 is a C1-C2 alkyl group, NH-(GP), N=(GP) where GP is a metabolisable substituent; the other of R1 and R2 is selected from the group consisting of CH3, C2H5, OCH3, OC2H5, SCH3, NH(R5), N(R5)2, N(R5)GP, N(R5)C(O)-amino acid in which R5 is an alkyl group; X is selected from the group consisting of O, NOH, NO(R3), in which R3 is selected from the group consisting of H, linear or branched alkyl, cycloalkyl, halogenated alkyl, substituted cycloalkyl, halogenated cycloalkyl, halogenated cycloalkyl, aralkyl or substituted aralkyl; Ar is selected from groups containing di-, tri- and tetra- methoxyphenyls, ethylene dioxies, or methylene dioxies. Also disclosed is a pharmaceutical composition of the above drug used in the preparation of a medicament inhibiting the polymerization of tubulin, thereby promoting tumour necrosis and treating cancer.
Patent NZ-536655-A (NZ)
Title: Oil soluble pigment compositions comprising at least one xanthophyll and at least one suitable solvent
Inventor: LEIGH STEVE
IPC: A23L33/15
Filed: 2003-05-28
Abstract: A process for the preparation of an oily solution of a physiologically acceptable pigment additive which comprises preparing a solid composition or a solution comprising a carotenoid and a lipophilic dispersing agent and dissolving or mixing the composition in oil. The process results in improved colouring effects.
Patent NZ-536741-A (NZ)
Title: Reciprocating slat conveyor with fixed and movable slats
Inventor: FOSTER RAYMOND KEITH
IPC: B65G25/06
Filed: 2004-11-23
Abstract: A reciprocating slat conveyor is composed of laterally spaced apart movable conveyor slats (10) and fixed conveyor slats (12) laterally between the movable slats (10). The movable slats (10) are clamped to transverse drive beams (56) by clamp structure that includes an upper clamp member (62) and a lower clamp surface (70) carried by the transverse drive beam (56). Bottom flanges (66, 68) on channel members (60) are clamped between the clamp member (72) and the clamp surface (70). The channel member (60) is connected to a central portion (32) depending from the movable slat top wall (14, 16). Portions (30, 32) carry bottom members (34) having side portions (36, 38). The side portions (36, 38) are in contact with lower bearing surfaces (42, 44). The top wall members (14, 16) of the conveyor slats (10) rest on the upper portions of the bearings (28, 30). An apron (84) extends laterally across the rear end portion of the conveyor. Apron (84) slopes downwardly and rearwardly from the front end (86) to a rear end (88). The movable conveyor slats (10) have rear end portions which move back and forth above a space defined by the apron (84) and a rear door (82) on the conveyor.
Patent NZ-539482-A (NZ)
Title: Expression of recombinant proteins and expression vectors in conjuction with expression of high molecular weight haemophilus
Inventor: LOOSMORE SHEENA M
Filed: 2001-05-03
Abstract: An expression vector which comprises a nucleic acid molecule, selected from hmwB and HmwC, encoding a high molecule weight protein of a non-typeable strain of Haemophilus and a promoter operatively connects to the nucleic acid molecule to direct expression of the high molecule protein in the host cell.